Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – In patients with hypertensive nephropathy and metabolic acidosis, alkali treatment reduces tubulointerstitial injury and slows the decline in glomerular filtration rate (GFR), a…
NEW YORK (Reuters Health) – Starting heparin in the emergency department (ED) rather than after admission may improve the survival of patients with acute pulmonary embolism (PE), according…
Joshua Grill, PhD, Director, Katherine and Benjamin Kagan Alzheimer’s Disease Treatment Development Program, UCLA, discusses new therapies for Alzheimer’s Disease. The FDA has currently approved 5 symptomatic therapies…
NEW YORK (Reuters Health) – The pure class III anti-arrhythmic drug nifekalant is more effective than lidocaine for terminating refractory ventricular fibrillation (VF) or ventricular tachycardia (VT), Japanese…
NEW YORK (Reuters Health) – Treating septic shock with steroids produces hyperglycemia, but patients are no better off with intensive insulin therapy than with conventional glucose control, according…
NEW YORK (Reuters Health) – In patients with middle cerebral artery occlusion, an alteplase dosage of 0.6 mg/kg IV is comparable to a 0.9 mg/kg dosage for achieving…
NEW YORK (Reuters Health) – It makes no difference whether internal tocodynamometry or external monitoring is used during induced or augmented labor – either way, the rate of…
NEW YORK (Reuters Health) – When paroxysmal atrial fibrillation has not responded to at least one antiarrhythmic agent, radiofrequency catheter ablation is more effective at preventing further episodes…
NEW YORK (Reuters Health) – The biomarker procalcitonin can help guide treatment of severe bacterial infections in the intensive care unit (ICU), French investigators report online in The…
NEW YORK (Reuters Health) – Giving beta-blockers within 8 hours of presentation with acute coronary syndrome (ACS) does not reduce in-hospital mortality, a meta-analysis has shown. Beta-blockers reduce…
